Header cover image

Canadian (TSX) Biotech Industry Analysis

UpdatedJan 24, 2025
DataAggregated Company Financials
Companies26
  • 7D-1.1%
  • 3M-15.5%
  • 1Y11.8%
  • YTD-1.8%

The Biotech is pretty flat in the last 7 days, but ME Therapeutics Holdings has stood out, gaining 23%. The past year has been better, since the industry has gained 19% in that time. Looking forward, earnings are expected to remain mostly flat in the next few years.

Industry Valuation and Performance

Has the Canadian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 24 Jan 2025CA$1.5bCA$87.5m-CA$318,059,042.0325.9x-4.7x17.1x
Sun, 22 Dec 2024CA$1.5bCA$85.5m-CA$330,832,137.9415.4x-4.4x17x
Tue, 19 Nov 2024CA$1.3bCA$83.3m-CA$248,916,369.038.6x-5.1x15.1x
Thu, 17 Oct 2024CA$1.3bCA$80.3m-CA$279,545,279.849x-4.7x16.3x
Sat, 14 Sep 2024CA$947.2mCA$80.3m-CA$282,348,766.819.4x-3.4x11.8x
Mon, 12 Aug 2024CA$1.1bCA$76.1m-CA$325,799,137.9611.1x-3.4x14.3x
Wed, 10 Jul 2024CA$1.1bCA$76.1m-CA$335,903,967.6810.6x-3.4x14.8x
Fri, 07 Jun 2024CA$1.2bCA$76.8m-CA$341,614,172.2911.3x-3.6x16.1x
Sun, 05 May 2024CA$911.8mCA$78.8m-CA$301,405,544.77317.4x-3x11.6x
Tue, 02 Apr 2024CA$1.1bCA$88.1m-CA$313,844,503.3011.1x-3.6x12.8x
Thu, 29 Feb 2024CA$1.3bCA$93.2m-CA$321,480,833.4510.7x-4x13.7x
Sat, 27 Jan 2024CA$3.5bCA$86.3m-CA$516,590,021.006.9x-6.8x41x
Mon, 25 Dec 2023CA$3.6bCA$86.1m-CA$521,808,413.006.9x-6.9x41.7x
Wed, 22 Nov 2023CA$3.8bCA$86.7m-CA$545,090,789.005.5x-7x44.3x
Fri, 20 Oct 2023CA$3.8bCA$89.0m-CA$532,712,398.005.2x-7.1x42.3x
Sun, 17 Sep 2023CA$3.9bCA$88.8m-CA$517,650,902.005.7x-7.6x44.3x
Tue, 15 Aug 2023CA$4.0bCA$85.8m-CA$523,663,687.006.9x-7.6x46.7x
Thu, 13 Jul 2023CA$4.1bCA$81.5m-CA$516,136,071.0013.2x-7.9x50.1x
Sat, 10 Jun 2023CA$3.9bCA$86.5m-CA$548,508,397.0011.5x-7.1x44.7x
Mon, 08 May 2023CA$3.8bCA$82.3m-CA$581,680,732.0012.3x-6.5x45.9x
Wed, 05 Apr 2023CA$2.4bCA$90.5m-CA$600,699,509.009.5x-4x26.3x
Fri, 03 Mar 2023CA$2.7bCA$90.4m-CA$590,404,646.008.2x-4.6x29.8x
Sun, 29 Jan 2023CA$3.0bCA$86.5m-CA$523,179,882.0011.3x-5.8x34.9x
Tue, 27 Dec 2022CA$3.1bCA$87.6m-CA$534,348,821.0010.3x-5.7x34.8x
Thu, 24 Nov 2022CA$3.1bCA$88.1m-CA$573,926,479.0014.8x-5.4x35.1x
Sat, 22 Oct 2022CA$3.1bCA$86.1m-CA$551,596,803.0015.1x-5.6x35.8x
Mon, 19 Sep 2022CA$3.4bCA$85.1m-CA$539,656,961.0013.5x-6.3x39.8x
Wed, 17 Aug 2022CA$3.5bCA$84.4m-CA$520,907,009.0013.8x-6.6x40.9x
Fri, 15 Jul 2022CA$3.5bCA$183.4m-CA$611,495,266.0010.1x-5.8x19.3x
Sun, 12 Jun 2022CA$3.1bCA$180.3m-CA$594,902,790.0013.2x-5.2x17.3x
Tue, 10 May 2022CA$3.2bCA$182.9m-CA$479,551,218.0012.6x-6.6x17.3x
Thu, 07 Apr 2022CA$3.6bCA$170.3m-CA$480,928,805.0015.2x-7.4x20.9x
Sat, 05 Mar 2022CA$3.1bCA$170.1m-CA$473,897,140.0015.5x-6.6x18.5x
Mon, 31 Jan 2022CA$3.2bCA$168.1m-CA$434,585,446.0018.4x-7.4x19.2x
Price to Earnings Ratio

-7.4x


Total Market Cap: CA$3.2bTotal Earnings: -CA$434,585,446.00Total Revenue: CA$168.1mTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Biotech Industry Price to Earnings3Y Average -5.6x202320242025
Current Industry PE
  • Investors are pessimistic on the Canadian Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 28.5x is higher than the industry's current PS ratio of 18.2x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 20% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the Canadian Healthcare industry?

CA Market2.29%
Healthcare0.071%
Biotech-1.12%
Biotech-1.12%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ONCO Onco-InnovationsCA$2.2051.7%
+CA$32.5m
n/aPB2794.6x
METX ME Therapeutics HoldingsCA$7.0011.3%
+CA$17.9m
586.3%n/a
HEM HemostemixCA$0.3527.3%
+CA$10.5m
366.7%PE-24.7x
MBX Microbix BiosystemsCA$0.5013.6%
+CA$8.1m
25.0%PE19.3x
EDT Spectral MedicalCA$0.514.1%
+CA$6.4m
0%PS72.3x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ONCO

CA$2.20

Onco-Innovations

7D

51.7%

1Y

n/a

ONC

CA$1.17

Oncolytics Biotech

7D

-3.3%

1Y

-31.2%

DRUG

CA$46.15

Bright Minds Biosciences

7D

-14.7%

1Y

1,791.4%

METX

CA$7.00

ME Therapeutics Holdings

7D

11.3%

1Y

586.3%

EPRX

CA$4.31

Eupraxia Pharmaceuticals

7D

-1.6%

1Y

-19.9%

MBX

CA$0.50

Microbix Biosystems

7D

13.6%

1Y

25.0%

HBP

CA$0.93

Helix BioPharma

7D

-5.1%

1Y

-13.5%

COV

CA$3.18

Covalon Technologies

7D

-4.2%

1Y

197.2%

EDT

CA$0.51

Spectral Medical

7D

4.1%

1Y

0%

DTC

CA$0.80

Defence Therapeutics

7D

19.4%

1Y

-58.3%

SVA

CA$0.20

Sernova

7D

-11.4%

1Y

-66.9%

WLLW

CA$0.03

Willow Biosciences

7D

-60.0%

1Y

-72.7%

TELO

CA$0.16

Telo Genomics

7D

52.4%

1Y

-3.0%

MSCL

CA$0.88

Satellos Bioscience

7D

6.0%

1Y

93.4%

HEM

CA$0.35

Hemostemix

7D

27.3%

1Y

366.7%

GLAB

CA$0.55

Gemina Laboratories

7D

-12.7%

1Y

1.9%